Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
0.68505
+0.0141 (2.09%)
At close: Nov 18, 2026, 4:00 PM EST
0.6797
-0.0054 (-0.78%)
After-hours: Nov 18, 2026, 4:45 PM EST
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of $8.74 million as of November 18, 2026. Its market cap has decreased by 78.20% in one year.
Market Cap
8.74M
Enterprise Value
4.37M
1-Year Change
-78.20%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from $72.85M to $8.74M, a decrease of -88.01%. That is a compound annual growth rate of -34.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 8.78M | -85.15% |
| Dec 31, 2025 | 59.10M | 81.41% |
| Dec 31, 2024 | 32.58M | 73.79% |
| Dec 29, 2023 | 18.75M | -20.04% |
| Dec 30, 2022 | 23.45M | -67.78% |
| Dec 31, 2021 | 72.76M | -0.12% |
| Nov 25, 2021 | 72.85M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Palatin Technologies | 9.41M |
| BioLineRx | 9.34M |
| Lexaria Bioscience | 9.02M |
| Cellectar Biosciences | 8.89M |
| Vistagen Therapeutics | 8.85M |
| Daré Bioscience | 8.85M |
| Lisata Therapeutics | 8.83M |
| Intensity Therapeutics | 8.72M |